Pinealon Peptide: The EDR Research Record and Where to Buy It (2026)

Two rodent models used very different study designs

The first in vivo step was a prenatal-hyperhomocysteinemia rat model. Investigators administered Pinealon to maternal rats intraperitoneally at 10 micrograms/kg body weight once daily during the five days before methionine loading. In the offspring, the EDR group showed better spatial orientation and learning measures. Isolated offspring cerebellar neurons also showed lower reactive oxygen species and fewer necrotic cells. The amount, route, timing, and outcomes belong to this specific prenatal rat experiment; they are not research-use guidance.

The later animal study used 5xFAD mice, a model selected for Alzheimer-related research. Investigators administered EDR intraperitoneally at 400 micrograms/kg once daily for two months. Compared with saline-control 5xFAD mice, the EDR group had CA1 dendritic-spine density 11% higher in males and 12% higher in females. The same study used molecular docking to propose possible binding sites in several gene promoters. Both the spine-density result and the docking analysis came from the 5xFAD mouse experiment. The percentage differences are relative findings within that mouse design, not evidence of an established effect in people.

These two models should not be blended into a single dose story. The rat work used 10 micrograms/kg for five days before a defined experimental challenge. The mouse work used 400 micrograms/kg daily for two months. Both used intraperitoneal administration, but neither the amount nor the duration matched. Species, model, timing, endpoints, and study purpose all changed at once.

The human record comes from older reports

A 2015 unregistered report described combined Pinealon and Vesugen administration in people aged 41 to 83 years with chronic polymorbidity and organic brain syndrome in remission. Its abstract says 32 people, then separately lists 18 men and 12 women, which totals 30. More importantly for compound evaluation, the report used two peptides together, so its observations cannot be assigned specifically to Pinealon.

Another unregistered 2012 occupational report examined 150 lorry drivers and 150 metal-craftsmen controls. Its strongest presented result followed combined Pinealon and Vesugen administration. The combined design again prevents isolation of a Pinealon-specific effect. A ClinicalTrials.gov search for Pinealon returned zero studies on August 25, 2026. Under that name the registry holds no trial and no posted result.

EDR identity is clear at the compound level

The PubChem record for CID 10273502 identifies Pinealon as Glu-Asp-Arg, or EDR, gives CAS 175175-23-2, and lists "Pinealon acetate salt form" among the synonyms. The neutral parent carries formula C15H26N6O8 and molecular weight 418.40 g/mol.

The FDA UNII Search Service returns no record for PINEALON, and that result does not determine FDA approval or legal status. It means a Pinealon lot cannot be checked by matching the name to a returned UNII. Identity review instead has to stay attached to the exact product label, lot number, material form, and lot-specific analytical result. Curo explains the analytical expectations in its quality and testing standard, alongside the intended-use boundary on the research-use-only page.

This distinction is practical. A catalogue name and size identify what was listed for sale. They do not show that the supplied material is the neutral parent, an acetate form, or the same material used in any paper. Lot-level documentation is what connects a physical item to its stated identity.

Is Pinealon legal to buy?

In the United States, Pinealon is legal to purchase as a research chemical for laboratory use. It is not a controlled substance and does not appear on any DEA schedule as of August 2026. What it also is not: an approved drug, a dietary supplement ingredient, or a compound cleared for human or veterinary use in any form.

Three boundaries define the current legal picture:

1. Research sale is lawful; human-use marketing is not. The FDA has repeatedly cited peptide sellers whose sites promote human use. The owner of one vendor, Paradigm Peptides, was sentenced to 70 months in federal prison in July 2026 for selling unapproved and adulterated drugs. The offense was not stocking peptides. It was selling them for human consumption while faking the paperwork.
2. Sport rules are stricter than trade law. Pinealon is not named on the WADA 2026 Prohibited List, but the S0 category covers non-approved substances as a class, and Pinealon has no approval anywhere. Tested athletes should treat it as covered.
3. There is no lawful compounded or prescription form. Pinealon was not among the peptides FDA's Pharmacy Compounding Advisory Committee reviewed for the 503A bulk substances list in July 2026, so no pharmacy route exists for it as of August 2026.

None of this changes how a supplier like Curo operates: Pinealon is sold strictly for laboratory research, not for human or animal use. Curo's research use only policy covers what that means in practice.

Where to buy Pinealon for laboratory research

Researchers looking for where to buy Pinealon face a supplier market that changed sharply in 2025 and 2026. Peptide Sciences closed in March 2026, Amino Asylum went offline after a reported federal raid in June 2025, and Paradigm Peptides ended in a criminal sentencing. Several sites now trade on those dead brand names, so the first check is not price. It is whether the company behind the storefront actually exists. Our guide to the best peptide companies in 2026 covers the current field vendor by vendor.

Pinealon raises one extra problem on top of the usual checks. Because the FDA UNII service has no record under the name, and because supplier pages disagree with each other on the formula and molecular weight, the compound cannot be confirmed by catalogue text at all. Several storefronts list weights of 328, 384, 388, 418, or 432 g/mol for the same product name. Only the lot certificate settles which material is in the vial.

Five checks separate a documented Pinealon source from an anonymous one:

1. A lot-specific COA, published before purchase. The certificate should match the exact lot on the vial, not a generic product-page badge. The help center shows how to verify a certificate against your lot.
2. A named, independent laboratory. A COA is only as good as the lab that issued it. Court records in the Paradigm case showed the defendants admitted faking certificates outright, which is the failure mode this check exists to catch.
3. Identity and purity by more than one method. HPLC purity alone leaves an identity gap, and for Pinealon that gap is wide because the name resolves to no registry entry. Look for mass-spectrometry identity confirmation against 418.40 g/mol, plus endotoxin results.
4. An identifiable company. A legal entity, a real contact route, and consistent policies. A brand name alone is not an identity, and the clone sites trading on dead vendors prove it.
5. Payment with recourse. Card payment carries buyer protection. Venmo, Zelle, and crypto-only checkouts remove it.

Curo stocks Pinealon 10mg in the research catalogue. Every lot is tested by an independent laboratory for identity, purity, and endotoxin, the full testing standard is documented, and every certificate is publicly readable without an account. Orders are fulfilled from the United States, and payment options include card, crypto, Zelle, and Cash App.

How much does Pinealon cost?

As of August 2026, research-grade Pinealon in the 10mg vial size typically runs $45 to $85 from US suppliers that publish lot-matched, independently issued COAs. Cheaper vials exist, some under $40, but they cluster among suppliers with no published lot documentation, and an unverified lot is unusable as research material at any price. Curo's Pinealon 10mg is $69, inside that documented range. Compare the documentation attached to the current batch first, then the price. The pre-purchase checklist walks the full sequence.

That 10 mg is a vial size and has nothing to do with the per-kilogram amounts the animal papers used. The catalogue figure describes what was listed for sale, nothing else.

What a Pinealon certificate of analysis should show

Pinealon is synthesized by many suppliers, so material quality is something a lab confirms rather than assumes. Identity, purity, endotoxin load, and fill accuracy all vary by manufacturer and by lot. A certificate worth relying on shows:

• The exact lot number that appears on the vial.
• The issuing laboratory's name and report identifier.
• HPLC purity with the chromatogram, not a bare percentage.
• Mass-spectrometry identity confirmation against the expected 418.40 g/mol for the neutral parent, with the salt form stated if the material is an acetate.
• An endotoxin result, since a pure peptide can still carry bacterial contamination from synthesis.
• A way to verify the document independently, through a public lookup or the lab itself. Curo's COA database is open for exactly this reason.

A well-tested lyophilized peptide can still be degraded by poor handling after receipt. See storing research peptides and bacteriostatic water for the storage side.

For a broader framework on separating documentation from marketing when comparing suppliers, see how to evaluate research peptide companies and the companion piece on purity claims and COA batch documentation.

Further reading

Epithalon is the closest sibling compound, from the same Khavinson programme and the same institute, and its record is longer: cultured human cells, a 2025 study describing a second telomere-lengthening route in cancer lines, and rhesus monkeys. That contrast in evidence depth is set out in Epithalon's record from cell culture to primates.

For a peptide from the same Russian research tradition examined in anxiety and cytokine work, follow the Selank review.

The Semax registry review shows how a heavily published Russian compound looks when viewed through US registries, and how differently that record reads once FDA's compounding committee takes it up.

Frequently asked questions

Is Pinealon legal to buy in the US?

Yes, as a research chemical for laboratory use. Pinealon is not a controlled substance as of August 2026. It is not approved for human use, no lawful compounded or prescription form exists, and its lack of approval anywhere means tested athletes should treat it as covered by WADA's S0 category.

Where can a researcher buy Pinealon?

From suppliers that publish lot-specific, independently issued COAs and operate as identifiable companies. Several well-known vendors closed or faced federal action in 2025 and 2026, and clone sites now trade on their names, so verify the company before the price. Curo lists Pinealon 10mg for laboratory research with every lot's certificate published openly.

How much does Pinealon cost?

Suppliers that publish lot-matched third-party COAs typically charge $45 to $85 for a 10mg research vial as of August 2026. Curo's 10mg vial is $69 with the lot's certificate published before purchase. Vials under that range usually come without verifiable lot documentation.

What is the most notable Pinealon result so far?

The clearest quantitative result is the 5xFAD mouse finding: CA1 dendritic-spine density was 11% higher in males and 12% higher in females than in saline-control 5xFAD mice after the study's two-month EDR regimen. It remains a model-specific preclinical result.

Do the cell studies establish Pinealon's mechanism in people?

No. They show lower oxidative-stress-associated markers and necrotic cell death in cultured systems, plus fluorescent localization and in vitro nucleic-acid interactions. They generate mechanism hypotheses but do not establish a validated human target.

Is the 10 mg catalogue item comparable to the animal-study amounts?

No. The catalogue figure is the total listed product size. The animal papers report amounts per kilogram administered under their own experimental designs. Neither converts the catalogue item into a protocol or a known safe human amount.

What should be checked before evaluating a Pinealon lot?

Match the product label and lot number to the batch-specific certificate, then review the stated identity method and result. Because no UNII record exists for the name and supplier pages disagree on the molecular weight, mass-spectrometry identity against 418.40 g/mol matters more here than for most compounds.

Is there any registered clinical trial of Pinealon?

No. A ClinicalTrials.gov search under the name returned zero studies on August 25, 2026. The two human reports in the literature are unregistered and both administered Pinealon together with a second peptide, so neither isolates a Pinealon-specific effect.